Patent application number | Description | Published |
20090202446 | MICROEMULSION COMPOSITION FOR AIR FRESHENER - The present invention relates to air freshener devices of water-based liquid compositions, preferably clear liquids, that provide an improved diffusion of the composition and allow the use of fragrance materials with a wide range of characteristics, namely a wide range of clogP values. The compositions are clear microemulsions particularly adapted for use in automatic air fresheners and comprise at least 40% w/w of an aqueous phase, preferably water, an active oil in an amount of between 0.01 and 5% w/w, an oil-solubilizing system which is formed of a surfactant mixture of ionic and non-ionic surfactants, a solubilizing-aid ingredient in an amount of up to 5% w/w, and a propellant system in an amount of up to 40% w/w, wherein the perfume oil to total surfactant mixture is present at a weight ratio of between 0.2 and 4.5. | 08-13-2009 |
20100098644 | SOLUBILIZING SYSTEMS FOR FLAVORS AND FRAGRANCES - The present invention provides compositions and clear oil-in-water microemulsion containing up to 80% w/w of an oil, a surfactant system, a w/w oil/surfactant system ratio between 1 and 3, and a solubilizing-aid ingredient which is not a surfactant neither a VOC compound, the latter being present in an amount sufficient to ensure that the ratio oil/(surfactant+solubilizing aid) is comprised between 0.1 and 5. The present invention concerns also the articles and products associated the compositions and microemulsions, and the methods to manufacture them. | 04-22-2010 |
20100136175 | CLEAR FLAVOR MICROEMULSIONS COMPRISING SUGAR ESTERS OF FATTY ACIDS - Formulations of clear, thermodynamically stable and concentrated oil-in-water microemulsions are disclosed, comprising a surfactant system which is formed of a sugar ester of a fatty acid together with lecithin, as well as their use for the flavoring of clear beverages. | 06-03-2010 |
20120097754 | WATER-BASED AIR FRESHENER COMPOSITIONS, SYSTEMS, AND METHODS OF USE THEREOF - Air freshener compositions, devices, and methods are disclosed. | 04-26-2012 |
Patent application number | Description | Published |
20080311073 | Ilt3 Polypeptides and Uses Thereof - This invention provides a first polypeptide comprising all or a portion of the extracellular domain of ILT3, wherein the polypeptide is water-soluble and does not comprise the Fc portion of an immunoglobulin. This invention also provides a second polypeptide comprising (i) all or a portion of the extracellular domain of ILT3 operable affixed to (ii) the Fc portion of an immunoglobulin, wherein the Fc portion of the immunoglobulin comprises a function-enhancing mutation, and wherein the polypeptide is water-soluble. This invention further provides a third polypeptide comprising (i) all or a portion of the extracellular domain of ILT3 operable affixed to (ii) a transmembrane domain. This invention further provides related nucleic acids, expression vectors, host vector systems, compositions, and articles of manufacture and therapeutic and prophylactic methods using the polypeptides of the invention. | 12-18-2008 |
20090202544 | Methods of Treating Diseases by Targeting Silt3 - This invention provides a method of treating a subject afflicted with a disease, comprising withdrawing blood from the subject, treating the withdrawn blood so as to remove sILT3 from the blood, and returning the treated blood to the subject, thereby treating the subject afflicted with the disease. This invention also provides the above method, further comprising administering an anti-ILT3 antibody to the subject. The invention also provides a method of treating a subject afflicted with a disease, comprising administering to the subject an anti-ILT3 antibody, thereby treating the subject. In one embodiment, the disease is chronic viral disease. In another embodiment, the disease is cancer. | 08-13-2009 |
20090274685 | ILT3 POLYPEPTIDES AND USES THEREOF - This invention provides a method for inhibiting the rejection of transplanted islet cells, comprising administering to the subject a polypeptide comprising all or a portion of the extracellular domain of ILT3, wherein the polypeptide is water soluble. This invention further provides a method of treating diabetes, by inhibiting the rejection of transplanted islet cells through the administration of the polypeptide to the subject. | 11-05-2009 |
20120321623 | ILT3 Polypeptides and Uses Thereof - This invention provides a first polypeptide comprising all or a portion of the extracellular domain of ILT3, wherein the polypeptide is water-soluble and does not comprise the Fc portion of an immunoglobulin. This invention also provides a second polypeptide comprising (i) all or a portion of the extracellular domain of ILT3 operable affixed to (ii) the Fc portion of an immunoglobulin, wherein the Fc portion of the immunoglobulin comprises a function-enhancing mutation, and wherein the polypeptide is water-soluble. This invention further provides a third polypeptide comprising (i) all or a portion of the extracellular domain of ILT3 operable affixed to (ii) a transmembrane domain. This invention further provides related nucleic acids, expression vectors, host vector systems, compositions, and articles of manufacture and therapeutic and prophylactic methods using the polypeptides of the invention. | 12-20-2012 |
20130156763 | ILT3 Polypeptides and Uses Thereof - This invention provides a method for inhibiting the rejection of transplanted islet cells, comprising administering to the subject a polypeptide comprising all or a portion of the extracellular domain of ILT3, wherein the polypeptide is water soluble. This invention further provides a method of treating diabetes, by inhibiting the rejection of transplanted islet cells through the administration of the polypeptide to the subject. | 06-20-2013 |
20150110714 | Diagnosis and Treatment of Cancer Expressing ILT3 or ILT3 Ligand - The present invention relates to methods of using the expression of ILTL3 ligand or ILT3 on certain types of cancer cells as a diagnostic tool. Methods are provided for treating ILT3-ligand expressing cancers, such as T-cell acute lymphoblastic leukemia (T-cell acute lymphoblastic leukemia), for example by administering ILT3, the extracellular domain of ILT3 or ILT3Fc conjugated to a cytotoxic agent to kill the targeted cancer cell. Other methods are provided for treating cancers that express ILT3 on their surface, such as monocytic forms of AML, for example by administering anti-ILT3 antibodies conjugated to a cytotoxic agent. | 04-23-2015 |
Patent application number | Description | Published |
20090039029 | IRON OXIDE RECOVERY - A method for increasing recovery of particulate material from a fluid stream includes directing the fluid stream through a channel, conditioning the fluid stream by applying energy to the fluid stream sufficient to increase concentration of the particulate material, and recovering the particulate material from the fluid stream. The particulate material of interest may be iron oxide in stream of water. The step of applying energy may be performed by applying an electric field or a magnetic field to the fluid stream to facilitate the separation process. | 02-12-2009 |
20090306354 | EGGSHELL MEMBRANE SEPARATION METHOD - A method for processing unseparated egg shells is provided. The method includes placing the unseparated egg shells in a fluid tank containing a fluid mixture, applying cavitation to the fluid mixture to thereby assist in separating the egg shell membranes from the egg shells, and recovering the egg shell membranes. Preferably, the fluid mixture is recirculated to thereby provide for continuous processing of unseparated egg shells. The method may further include drying the egg shell membranes to produce dried egg shell membranes which may then be vacuum packaged for storage and/or transport. The dried egg shell membranes may then be subjected to an extraction process for extracting at least one type of polypeptide from the egg shell membranes. Collagen, hyaluronic acid, or amino acids of interest may be extracted from the egg shell membrane and purified for numerous uses. | 12-10-2009 |
20100175570 | EGGSHELL MEMBRANE SEPARATION METHOD - A method for processing unseparated egg shells is provided. The method includes placing the unseparated egg shells in a fluid tank containing a fluid mixture, applying cavitation to the fluid mixture to thereby assist in separating the egg shell membranes from the egg shells, and recovering the egg shell membranes. Preferably, the fluid mixture is recirculated to thereby provide for continuous processing of unseparated egg shells. The method may further include drying the egg shell membranes to produce dried egg shell membranes which may then be vacuum packaged for storage and/or transport. The dried egg shell membranes may then be subjected to an extraction process for extracting at least one type of polypeptide from the egg shell membranes. Collagen, hyaluronic acid, or amino acids of interest may be extracted from the egg shell membrane and purified for numerous uses. | 07-15-2010 |
20110303771 | EGG SHELL MEMBRANE SEPARATION - A method for processing unseparated egg shells includes placing unseparated egg shells in a separation tank containing fluid, applying cavitation to the unseparated egg shells in the fluid to thereby separate the egg shell membranes from the egg shells, and recovering the egg shell membranes. An apparatus for processing unseparated egg shells includes a separation tank for holding a fluid, a recirculating loop operatively connected to the separation tank, and at least one submersible mixer in the recirculating loop to recirculate the fluid and egg shell membranes and egg shells within the fluid. The apparatus further includes a membrane collection conveyor for conveying egg shell membranes from the separation tank and a shell conveyor positioned beneath the separation tank for conveying egg shells away from the separation tank. | 12-15-2011 |